Trial intelligence / Profile preview

Masculinizing Effects of Initiating Testosterone Enanthate With or Without Finasteride in Transmasculine Persons

TCTR20250709010Phase 2Recruiting

Sponsor
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of testosterone enanthate, finasteride in gender dysphoria (GD), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Dec 2024; status: recruiting.

02

Drugs

testosterone enanthatefinasteride
03

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on TCTR20250709010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250709010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call